Harpoon Therapeutics
(NASDAQ) HARP
Harpoon Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$37.34M
Net Income (TTM)
$30.86M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
HARP News
HARP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Harpoon Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
50
CEO
Julia Marie Eastland, MBA
Website
www.harpoontx.comHeadquarters
South San Francisco, CA 94080, US
HARP Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-2%
Return on Capital
-3%
Return on Assets
-91%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$28.82M
Operating Income
$68.33M
EBITDA
$65.97M
Operating Cash Flow
$89.18M
Capital Expenditure
$347.00K
Free Cash Flow
$89.53M
Cash & ST Invst.
$53.11M
Total Debt
$16.01M
Harpoon Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.45M
-67.3%
Gross Profit
$4.21M
-67.4%
Gross Margin
94.69%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
45
N/A
Net Income
$1.80M
+84.2%
EBITDA
$3.61M
+66.6%
Quarterly Fundamentals
Net Cash
$17.10M
-69.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$11.53M
+26.1%
Short Term Debt
$2.97M
+62.7%
Return on Assets
-91.06%
N/A
Return on Invested Capital
-3.21%
N/A
Free Cash Flow
$16.62M
+31.4%
Operating Cash Flow
$16.53M
+31.0%